Partner/Partnering: Brca Positive And Triple Negative Breast Cancer Phase Ii Poor Responders Sub-Study To Establish If Post-Neoadjuvant, Pre-Surgical Addition Of Novel Therapies Improves Pathological Outcome At Surgery